The Board of Directors at their just concluded meeting has approved the un audited standalone and consolidated financial results for the second quarter ended september 30, 2025 as recommended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tierra Agrotech's board approved unaudited standalone and consolidated financial results for Q2 and H1 FY26 (ended Sept 30, 2025). Standalone revenue from operations jumped to ₹1,016.09 lakhs in Q2 from ₹603.94 lakhs a year earlier (~68% YoY), while H1 revenue rose to ₹6,207.49 lakhs from ₹5,598.44 lakhs. Despite the strong top-line, Q2 standalone profit after tax remained negative at a loss of ₹344.33 lakhs, though H1 swung to a PAT of ₹195.85 lakhs versus a loss in the year-ago period. The company also appointed Ranjith Mupparapu as the new CFO, redesignated Vijay Kumar Deekonda as Whole-time Director, and constituted a Strategic Growth and M&A Committee. Comparatives were restated to reflect the amalgamation of wholly owned subsidiary Tierra Seed Science Pvt Ltd, and the remaining 50% stake in Tidas Agrotech was acquired during the quarter.
Revenue growth is encouraging, but the persistent quarterly loss, sharply negative operating cash flow of ₹(1,699.83) lakhs in H1, and a steep rise in borrowings (from ~₹60 lakhs to ~₹1,782 lakhs) signal working-capital strain and weakening liquidity. The new M&A committee and Tidas Agrotech acquisition suggest the company is positioning for inorganic growth, which could be a positive strategic signal but also raises execution and integration risk for shareholders.